Showing 1 - 7 results of 7 for search 'Kanthou, C', query time: 0.02s
Refine Results
-
1
Tumour vascular disrupting agents: combating treatment resistance. by Tozer, G, Kanthou, C, Lewis, G, Prise, V, Vojnovic, B, Hill, S
Published 2008Journal article -
2
Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions. by Greco, O, Rossiter, S, Kanthou, C, Folkes, L, Wardman, P, Tozer, G, Dachs, G
Published 2001Journal article -
3
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate. by Lunt, S, Akerman, S, Hill, S, Fisher, M, Wright, V, Reyes-Aldasoro, C, Tozer, G, Kanthou, C
Published 2011Journal article -
4
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate by Jane Lunt, S, Akerman, S, Hill, S, Fisher, M, Wright, V, Reyes-Aldasoro, C, Tozer, G, Kanthou, C
Published 2011Journal article -
5
The vascular targeting agent combretastatin A-4-phosphate induces neutrophil recruitment to endothelial cells in vitro. by Brooks, A, Kanthou, C, Cook, I, Tozer, G, Barber, P, Vojnovic, B, Nash, G, Parkins, C
Published 2003Journal article -
6
Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies. by Akerman, S, Fisher, M, Daniel, R, Lefley, D, Reyes-Aldasoro, C, Lunt, S, Harris, S, Bjorndahl, M, Williams, L, Evans, H, Barber, P, Prise, V, Vojnovic, B, Kanthou, C, Tozer, G
Published 2013Journal article -
7
Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies by Akerman, S, Fisher, M, Daniel, R, Lefley, D, Reyes-Aldasoro, C, Lunt, S, Harris, S, Bjorndahl, M, Williams, L, Evans, H, Barber, P, Prise, V, Vojnovic, B, Kanthou, C, Tozer, G
Published 2013Journal article